MedPath

Salvage TACE for unresectable HCC: switching the chemotherapeutic agents.

Not Applicable
Conditions
nresectable hepatocellular carcinoma
Registration Number
JPRN-UMIN000015887
Lead Sponsor
Kanagawa Cancer Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1)HCC with macrovascular invasion and/or extrahepatic metastasis 2)Child-Pugh score =/> 10 3)Patients who cannot be performed TACE technically 4)Patients received previous cisplatin-based chemotherapy 5)Patients received previous systemic chemotherapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath